Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia

References

• Riley BP, McGuffin P. Linkage and associated studies of schizophrenia. Am J Med Genet 2000; 97: 23–44
   PubMed Web of Science ®Google Scholar
• Tsuang M. Schizophrenia: genes and environment. Biol Psychiatry 2000; 47: 210–220
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders4th edn. American Psychiatric Association, Washington, DC 1994
   Google Scholar
• Dean B. Signal transmission, rather than reception, is the underlying neurochemical abnormality in schizophrenia. Aust N Z J Psychiatry 2000; 34: 560–569
   PubMed Web of Science ®Google Scholar
• Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000; 28: 53–67
   PubMed Web of Science ®Google Scholar
• Hemby SE, Ginsberg SD, Brunk B, Arnold SE, Trojanowski JQ, Eberwine JH. Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch Gen Psychiatry 2002; 59: 631–640
   PubMed Web of Science ®Google Scholar
• Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry 2001; 6: 293–301
   PubMed Web of Science ®Google Scholar
• Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 2002; 22: 2718–2729
   PubMed Web of Science ®Google Scholar
• Iwamoto K, Bundo M, Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 2005; 14: 241–253
   PubMed Web of Science ®Google Scholar
• Altar CA, Jurata LW, Charles V, et al. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry 2005; 58: 85–96
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Volk DW, Eggan SM, et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 2003; 23: 6315–6326
   PubMed Web of Science ®Google Scholar
• Vawter MP, Crook JM, Hyde TM, et al. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr Res 2002; 58: 11–20
   PubMed Web of Science ®Google Scholar
• Mexal S, Frank M, Berger R, et al. Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers. Brain Res Mol Brain Res 2005; 139: 317–332
   PubMedGoogle Scholar
• Hakak Y, Walker JR, Li C, et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 2001; 98: 4746–4751
   PubMed Web of Science ®Google Scholar
• Vawter MP, Barrett T, Cheadle C, et al. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull 2001; 55: 641–650
   PubMed Web of Science ®Google Scholar
• Mimmack ML, Ryan M, Baba H, et al. Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc Natl Acad Sci USA 2002; 99: 4680–4685
   PubMed Web of Science ®Google Scholar
• Dean B, Keriakous D, Thomas EA, Scarr E. Understanding the pathology of schizophrenia: the impact of high-throughput screening of the genome and proteome in postmortem CNS. Curr Psychiatry Rev 2005; 1: 1–9
   Google Scholar
• Sutcliffe JG. Open-system approaches to gene expression in the CNS. J Neurosci 2001; 21: 8306–8309
   PubMed Web of Science ®Google Scholar
• Weinberger DR. Schizophrenia and the frontal lobe. Trends Neurosci 1988; 11: 367–370
   PubMed Web of Science ®Google Scholar
• Hill C, Keks N, Roberts S, et al. Problem of diagnosis in postmortem brain studies of schizophrenia. Am J Psychiatry 1996; 153: 533–537
   PubMed Web of Science ®Google Scholar
• Kingsbury AE, Foster OJ, Nisbet AP, et al. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res 1995; 28: 311–318
   PubMedGoogle Scholar
• Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. The Stanley foundation brain collection and neuropathology consortium. Schizophr Res 2000; 44: 151–155
   PubMed Web of Science ®Google Scholar
• Kane JM, McGlashan TH. Treatment of schizophrenia. Lancet 1995; 346: 820–825
   PubMed Web of Science ®Google Scholar
• Millar JK, Wilson-Annan JC, Anderson S, et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000; 9: 1415–1423
   PubMed Web of Science ®Google Scholar
• Marengo J, Harrow M, Herbener ES, Sands J. A prospective longitudinal 10-year study of schizophrenia's three major factors and depression. Psychiatry Res 2000; 97: 61–77
   PubMed Web of Science ®Google Scholar
• Meagher DJ, Quinn JF, Bourke S, et al. Longitudinal assessment of psychopathological domains over late-stage schizophrenia in relation to duration of initially untreated psychosis: 3-year prospective study in a long-term inpatient population. Psychiatry Res 2004; 126: 217–227
   PubMed Web of Science ®Google Scholar
• Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry 2003; 60: 585–594
   PubMed Web of Science ®Google Scholar
• Bustillo JR, Lauriello J, Rowland LM, et al. Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure. Schizophr Res 2002; 58: 313–321
   PubMed Web of Science ®Google Scholar
• Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A. Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 2001; 58: 148–157
   PubMed Web of Science ®Google Scholar
• Kanadia RN, Johnstone KA, Mankodi A, et al. A muscleblind knockout model for myotonic dystrophy. Science 2003; 302: 1978–1980
   PubMed Web of Science ®Google Scholar
• Begemann G, Paricio N, Artero R, Kiss I, Perez-Alonso M, Mlodzik M. muscleblind, a gene required for photoreceptor differentiation in Drosophila, encodes novel nuclear Cys3His-type zinc-finger-containing proteins. Development 1997; 124: 4321–4331
   PubMed Web of Science ®Google Scholar
• Artero R, Prokop A, Paricio N, et al. The muscleblind gene participates in the organization of Z-bands and epidermal attachments of Drosophila muscles and is regulated by Dmef2. Dev Biol 1998; 195: 131–143
   PubMed Web of Science ®Google Scholar
• Shang CA, Thompson BJ, Teasdale R, Brown RJ, Waters MJ. Genes induced by growth hormone in a model of adipogenic differentiation. Mol Cell Endocrinol 2002; 189: 213–219
   PubMed Web of Science ®Google Scholar
• Akasaka T, Lossos IS, Levy R. BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. Blood 2003; 102: 1443–1448
   PubMed Web of Science ®Google Scholar
• Meltzer HY, Jackman H, Arora RC. Brain and skeletal muscle monoamine oxidase activity in schizophrenia. Schizophr Bull 1980; 6: 208–212
   PubMed Web of Science ®Google Scholar
• Perini GI, Menegazzo E, Ermani M, et al. Cognitive impairment and (CTG)n expansion in myotonic dystrophy patients. Biol Psychiatry 1999; 46: 425–431
   PubMed Web of Science ®Google Scholar
• Meltzer HY. Cognitive factors in schizophrenia: causes, impact, and treatment. CNS Spectrum 2004; 9: 15–24
   PubMed Web of Science ®Google Scholar
• Sharma RP. Schizophrenia, epigenetics and ligand-activated nuclear receptors: a framework for chromatin therapeutics. Schizophr Res 2005; 72: 79–90
   Web of Science ®Google Scholar
• Meyer S, Temme C, Wahle E. Messenger RNA turnover in eukaryotes: pathways and enzymes. Crit Rev Biochem Mol Biol 2004; 39: 197–216
   PubMed Web of Science ®Google Scholar
• Ho TH, Charlet B, Poulos MG, Singh G, Swanson MS, Cooper TA. Muscleblind proteins regulate alternative splicing. EMBO J 2004; 23: 3103–3112
   PubMed Web of Science ®Google Scholar
• Lewis BP, Green RE, Brenner SE. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc Natl Acad Sci USA 2003; 100: 189–192
   PubMed Web of Science ®Google Scholar
• Lipska BK, Peters T, Hyde TM, et al. Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. Hum Mol Genet 2006; 15: 1245–1258
   PubMed Web of Science ®Google Scholar
• Chiba S, Hashimoto R, Hattori S, et al. Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus. J Neural Transm 2006; 113: 1337–1346
   PubMed Web of Science ®Google Scholar
• Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT. Neurobiology of schizophrenia. Neuron 2006; 52: 139–153
   PubMed Web of Science ®Google Scholar
• Thomson PA, Wray NR, Millar JK, et al. Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population. Mol Psychiatry ; :657–668 2005; 10: 616
   Web of Science ®Google Scholar
• Zhang F, Sarginson J, Crombie C, Walker N, St Clair D, Shaw D. Genetic association between schizophrenia and the DISC1 gene in the Scottish population. Am J Med Genet B Neuropsychiatry Genet 2006; 141: 155–159
   Web of Science ®Google Scholar
• Ekelund J, Hennah W, Hiekkalinna T, et al. Replication of 1q42 linkage in Finnish schizophrenia pedigrees. Mol Psychiatry 2004; 9: 1037–1041
   PubMed Web of Science ®Google Scholar
• Liu YL, Fann CS, Liu CM, et al. A single nucleotide polymorphism fine mapping study of chromosome 1q42.1 reveals the vulnerability genes for schizophrenia, GNPAT and DISC1: association with impairment of sustained attention. Biol Psychiatry 2006; 60: 554–562
   PubMed Web of Science ®Google Scholar
• Devon RS, Anderson S, Teague PW, et al. Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorder. Psychiatry Genet 2001; 11: 71–78
   PubMed Web of Science ®Google Scholar
• Tkachev D, Mimmack ML, Ryan MM, et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003; 362: 798–805
   PubMed Web of Science ®Google Scholar
• Redies C, Vanhalst K, Roy F. delta-Protocadherins: unique structures and functions. Cell Mol Life Sci 2005; 62: 2840–2852
   PubMed Web of Science ®Google Scholar
• Junghans D, Haas IG, Kemler R. Mammalian cadherins and protocadherins: about cell death, synapses and processing. Curr Opin Cell Biol 2005; 17: 446–452
   PubMed Web of Science ®Google Scholar
• Frank M, Kemler R. Protocadherins. Curr Opin Cell Biol 2002; 14: 557–562
   PubMed Web of Science ®Google Scholar
• Owen MJ, O'Donovan MC, Harrison PJ. Schizophrenia: a genetic disorder of the synapse?. BMJ 2005; 330: 158–159
   PubMed Web of Science ®Google Scholar
• Bahn S, Augood SJ, Ryan M, Standaert DG, Starkey M, Emson PC. Gene expression profiling in the post-mortem human brain: no cause for dismay. J Chem Neuroanat 2001; 22: 79–94
   PubMed Web of Science ®Google Scholar